Q3 2020 Holdings
Filed 2020-11-16 | 105 holdings | $459.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acutus Medical Inc(AFIB) | COM | 005111109 | $129.4M | 4,341,799 | 28.2% |
| Centene Corp del(CNC) | COM | 15135B101 | $106.6M | 1,828,000 | 23.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $48.9M | 1,617,826 | 10.6% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $45.0M | 17,720,000 | 9.8% |
| Adapthealth Corp(AHCO) | COM CL A | 00653Q102 | $37.3M | 1,710,674 | 8.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $24.3M | 802,511 | 5.3% |
| Alector Inc(ALEC) | COM | 014442107 | $15.4M | 1,461,978 | 3.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $15.3M | 4,456,519 | 3.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $14.5M | 614,156 | 3.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $13.4M | 2,561,554 | 2.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $5.0M | 464,252 | 1.1% |
| Cerus Corp(CERS) | COM | 157085101 | $533.0K | 85,143 | 0.1% |
| Invitae Corp | NOTE 2.000% 9/0 | 46185LAB9 | $267.7K | $163,385,000 | 0.1% |
| Mylan NV | SHS EURO | N59465109 | $196.9K | 13,274,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $196.0K | 2,304,900 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $172.9K | $115,776,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $142.4K | 1,832,767 | 0.0% |
| Aerie Pharmaceuticals Inc | NOTE 1.500%10/0 | 00771VAB4 | $120.1K | $149,600,000 | 0.0% |
| DFP Healthcare Acquisitns Co | UNIT 03/31/2025 | 23343Q209 | $114.3K | 10,460,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $96.0K | 704,000 | 0.0% |
| Nuvasive Inc | NOTE 2.250% 3/1 | 670704AG0 | $87.4K | $85,000,000 | 0.0% |
| Dexcom Inc | NOTE 0.750%12/0 | 252131AH0 | $85.9K | $34,000,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $78.0K | 5,144,539 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $72.7K | 2,418,772 | 0.0% |
| Pacira Biosciences(PCRX) | COM | 695127100 | $72.0K | 1,197,825 | 0.0% |
| Apellis Pharmaceuticals Inc | NOTE 3.500% 9/1 | 03753UAB2 | $69.7K | $64,825,000 | 0.0% |
| Graybug Vision Inc | COM SHS | 38942Q103 | $67.1K | 5,281,713 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $66.5K | 3,448,912 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $66.3K | 579,248 | 0.0% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $66.0K | $61,000,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $62.5K | 1,796,383 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $58.8K | 1,234,262 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $50.8K | 951,063 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $47.4K | 421,619 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $46.5K | $57,791,000 | 0.0% |
| Clovis Oncology Inc | NOTE 2.500% 9/1 | 189464AB6 | $44.1K | $49,064,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $43.6K | 448,000 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $41.1K | 1,897,047 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $39.6K | 776,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $37.6K | 405,386 | 0.0% |
| Owens & Minor Inc New(ACH) | COM | 690732102 | $37.1K | 1,477,000 | 0.0% |
| Xeris Pharmaceuticals Inc | NOTE 5.000% 7/1 | 98422LAA5 | $36.1K | $18,000,000 | 0.0% |
| Deerfield Healthcare Technol | UNIT 07/16/2025 | 244413209 | $35.7K | 3,360,000 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $34.4K | 695,523 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $32.5K | 5,767,409 | 0.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $30.2K | 1,150,299 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $29.7K | 961,215 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $29.4K | 497,000 | 0.0% |
| Quidel Corp | COM | 74838J101 | $28.6K | 130,521 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $28.6K | 6,949,416 | 0.0% |